Kimberly-Clark to Acquire Kenvue in $48.7 Billion Consumer Health Merger
TL;DR Summary
Kimberly-Clark is acquiring Kenvue, the maker of Tylenol and other consumer health products, in a nearly $49 billion deal, aiming to create a global health and wellness leader amid challenges faced by Kenvue following controversial claims linking acetaminophen to autism.
- Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue NPR
- Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion The New York Times
- Kimberly-Clark buys out Kenvue in $48.7B consumer health merger Fierce Pharma
- Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal CNN
- Stocks making the biggest moves premarket: Iren, Kenvue, Cipher Mining, New Gold and more CNBC
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
85%
274 → 40 words
Want the full story? Read the original article
Read on NPR